Signal transduction by the atopy-associated human thymic stromal lymphopoietin (TSLP) receptor depends on Janus kinase function

被引:2
作者
Wohlmann, Andreas [1 ]
Sebastian, Katrin [1 ]
Borowski, Andreas [1 ]
Krause, Sebastian [1 ,2 ]
Friedrich, Karlheinz [1 ]
机构
[1] Univ Jena, Inst Biochem 2, Sch Med, D-07743 Jena, Germany
[2] INVIGATE GmbH, D-07745 Jena, Germany
关键词
asthma bronchiale; cytokine receptors; JAK-STAT signaling; HUMAN EPITHELIAL-CELLS; ACTIVATION; CLONING; PROLIFERATION; INFLAMMATION; CYTOKINE; STAT5; REQUIRES; COMPLEX; DOMAIN;
D O I
10.1515/BC.2010.029
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
Thymic stromal lymphopoietin ( TSLP) is an interleukin-(IL)-7-like cytokine with emerging pathological importance for the development of atopic diseases such as allergic asthma bronchiale. The TSLP receptor ( TSLPR), a heterodimeric type I cytokine receptor, shares the IL-7R alpha-subunit with the IL-7 receptor system. The specific TSLPR alpha-chain shows similarities with the gamma c receptor chain, but has some unusual features within the receptor family in both its ligand-binding and cytoplasmic domain. The murine TSLPR signals via the signal transducers and activators of transcription STAT5 and STAT3, but is unique among cytokine receptors in that it activates STATs without the involvement of Janus (JAK) tyrosine kinases, but instead utilizes the Src type kinase Tec. Here, we show by Western blotting and reporter gene experiments in combination with the application of a specific JAK inhibitor that the human TSLP receptor, in contrast, requires the function of JAK1 and JAK2 for STAT activation. Moreover, we demonstrate that the human TSLPR mediates gene regulation not only through STAT5 and STAT3 but has also the potential to mediate transcription via STAT1. Our work should help to understand more thoroughly how TSLP triggers inflammatory responses in the course of atopic diseases.
引用
收藏
页码:181 / 186
页数:6
相关论文
共 6 条
  • [1] Expression analysis and specific blockade of the receptor for human thymic stromal lymphopoietin (TSLP) by novel antibodies to the human TSLPRα receptor chain
    Borowski, Andreas
    Vetter, Tina
    Kuepper, Michael
    Wohlmann, Andreas
    Krause, Sebastian
    Lorenzen, Thomas
    Virchow, Johann Christian
    Luttmann, Werner
    Friedrich, Karlheinz
    CYTOKINE, 2013, 61 (02) : 546 - 555
  • [2] Thymic stromal lymphopoietin (TSLP) secretion from human nasal epithelium is a function of TSLP genotype
    Hui, C. C. K.
    Yu, A.
    Heroux, D.
    Akhabir, L.
    Sandford, A. J.
    Neighbour, H.
    Denburg, J. A.
    MUCOSAL IMMUNOLOGY, 2015, 8 (05) : 993 - 999
  • [3] A versatile platform for activity determination of cytokines and growth factors based on the human TSLP (thymic stromal lymphopoietin) receptor
    Markovic, Iva
    Barthel, Tabea
    Schirmer, Matthias
    Delgado, Andres Gonzalez
    Wilhelm, Stefanie
    Krause, Sebastian
    Friedrich, Karlheinz
    Wohlmann, Andreas
    CYTOKINE, 2019, 113 : 228 - 237
  • [4] Stimulation of the histamine 4 receptor upregulates thymic stromal lymphopoietin (TSLP) in human and murine keratinocytes
    Schaper, Katrin
    Rossbach, Kristine
    Koether, Brigitta
    Stark, Holger
    Kietzmann, Manfred
    Werfel, Thomas
    Gutzmer, Ralf
    PHARMACOLOGICAL RESEARCH, 2016, 113 : 209 - 215
  • [5] Thymic stromal lymphopoietin induction by polyinosinic:polycytidylic acid in human keratinocytes is preferentially mediated through protein kinase R and retinoid-inducible gene I and not Toll-like receptor 3 Reply
    Takai, Toshiro
    Vu, Anh Tuan
    Le, Tuan Anh
    Kinoshita, Hirokazu
    Ushio, Hiroko
    Ikeda, Shigaku
    Ogawa, Hideaki
    Okumura, Ko
    JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY, 2009, 124 (04) : 864 - 865
  • [6] Human epidermal growth factor receptor 2 expressions and Janus-activated kinase/signal transducer and activator of transcription 3-suppressor of cytokine signaling 3 pathway may be associated with clinicopathological features and prognosis of gastric cancer
    Xu, Wenjing
    Fu, Jingwei
    Wu, Hao
    Sun, Weijian
    JOURNAL OF CANCER RESEARCH AND THERAPEUTICS, 2018, 14 : S311 - S318